Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 166
of 9Next
1:

Mass ivermectin treatment for onchocerciasis: lack of evidence for collateral impact on transmission of Wuchereria bancrofti in areas of co-endemicity.

Richards FO Jr, Eigege A, Pam D, Kal A, Lenhart A, Oneyka JO, Jinadu MY, Miri ES.

Filaria J. 2005 Jul 15;4:6.

PMID: 16022728 [PubMed]

3:

Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications.

Kyelem D, Sanou S, Boatin B, Medlock J, Coulibaly S, Molyneux DH.

Ann Trop Med Parasitol. 2003 Dec;97(8):827-38.

PMID: 14754495 [PubMed - indexed for MEDLINE]

4:

Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual, ivermectin-based, mass treatments in Nigeria.

Richards FO Jr, Pam DD, Kal A, Gerlong GY, Onyeka J, Sambo Y, Danboyi J, Ibrahim B, Terranella A, Kumbak D, Dakul A, Lenhart A, Rakers L, Umaru J, Amadiegwu S, Withers PC Jr, Mafuyai H, Jinadu MY, Miri ES, Eigege A.

Ann Trop Med Parasitol. 2005 Mar;99(2):155-64.

PMID: 15814034 [PubMed - indexed for MEDLINE]

5:

Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.

Kyelem D, Medlock J, Sanou S, Bonkoungou M, Boatin B, Molyneux DH.

Trop Med Int Health. 2005 Oct;10(10):1002-4.

PMID: 16185234 [PubMed - indexed for MEDLINE]

6:

Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.

Ramaiah KD, Das PK, Vanamail P, Pani SP.

Trans R Soc Trop Med Hyg. 2007 Jun;101(6):555-63. Epub 2007 Mar 19.

PMID: 17374389 [PubMed - indexed for MEDLINE]

7:

The prevalences of Wuchereria bancrofti antigenaemia in communities given six rounds of treatment with diethylcarbamazine, ivermectin or placebo tablets.

Ramaiah KD, Vanamail P, Pani SP, Das PK.

Ann Trop Med Parasitol. 2003 Oct;97(7):737-41.

PMID: 14613632 [PubMed - indexed for MEDLINE]

8:

Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province.

Bockarie MJ, Ibam E, Alexander ND, Hyun P, Dimber Z, Bockarie F, Alpers MP, Kazura JW.

P N G Med J. 2000 Sep-Dec;43(3-4):172-82.

PMID: 11939298 [PubMed - indexed for MEDLINE]

9:

Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India.

Das PK, Ramaiah KD, Vanamail P, Pani SP, Yuvaraj J, Balarajan K, Bundy DA.

Trans R Soc Trop Med Hyg. 2001 May-Jun;95(3):336-41.

PMID: 11491011 [PubMed - indexed for MEDLINE]

10:

Urban lymphatic filariasis in central Nigeria.

Terranella A, Eigiege A, Gontor I, Dagwa P, Damishi S, Miri E, Blackburn B, McFarland D, Zingeser J, Jinadu MY, Richards FO.

Ann Trop Med Parasitol. 2006 Mar;100(2):163-72.

PMID: 16492364 [PubMed - indexed for MEDLINE]

12:

The Mectizan Donation Program - highlights from 2005.

Alleman MM, Twum-Danso NA, Thylefors BI.

Filaria J. 2006 Sep 27;5:11.

PMID: 17005039 [PubMed]

13:

Community-directed treatment of onchocerciasis with ivermectin in Takum, Nigeria.

Akogun OB, Audu Z, Weiss MG, Adelakun AO, Akoh JI, Akogun MK, Remme H, Kale OO.

Trop Med Int Health. 2001 Mar;6(3):232-43.

PMID: 11299041 [PubMed - indexed for MEDLINE]

14:

Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection.

Vieira JC, Cooper PJ, Lovato R, Mancero T, Rivera J, Proaño R, López AA, Guderian RH, Guzmán JR.

BMC Med. 2007 May 23;5:9.

PMID: 17521449 [PubMed - indexed for MEDLINE]

15:

Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria.

Hopkins DR, Eigege A, Miri ES, Gontor I, Ogah G, Umaru J, Gwomkudu CC, Mathai W, Jinadu M, Amadiegwu S, Oyenekan OK, Korve K, Richards FO Jr.

Am J Trop Med Hyg. 2002 Sep;67(3):266-72.

PMID: 12408665 [PubMed - indexed for MEDLINE]

16:

Clinical characteristics of post-treatment reactions to ivermectin/albendazole for Wuchereria bancrofti in a region co-endemic for Mansonella perstans.

Keiser PB, Coulibaly YI, Keita F, Traore D, Diallo A, Diallo DA, Semnani RT, Doumbo OK, Traore SF, Klion AD, Nutman TB.

Am J Trop Med Hyg. 2003 Sep;69(3):331-5.

PMID: 14628953 [PubMed - indexed for MEDLINE]

17:

Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa.

Borsboom GJ, Boatin BA, Nagelkerke NJ, Agoua H, Akpoboua KL, Alley EW, Bissan Y, Renz A, Yameogo L, Remme JH, Habbema JD.

Filaria J. 2003 Mar 24;2(1):8.

PMID: 12769825 [PubMed - as supplied by publisher]

18:

Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.

Vanamail P, Ramaiah KD, Subramanian S, Pani SP, Yuvaraj J, Das PK.

Ann Trop Med Parasitol. 2005 Apr;99(3):237-42.

PMID: 15829133 [PubMed - indexed for MEDLINE]

19:

Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India.

Sunish IP, Rajendran R, Mani TR, Munirathinam A, Dash AP, Tyagi BK.

Bull World Health Organ. 2007 Feb;85(2):138-45.

PMID: 17308735 [PubMed - indexed for MEDLINE]

20:

Lymphatic filariasis in the Caribbean region: the opportunity for its elimination and certification.

Rawlins SC, Lammie P, Tiwari T, Pons P, Chadee DD, Oostburg BF, Baboolal S.

Rev Panam Salud Publica. 2000 May;7(5):319-24.

PMID: 10893972 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 166
of 9Next